$IDA

IDACORP Q2 Profit Rises, Lifts FY26 Earnings Guidance

IDACORP reported Q2 net income of $102.6 million, or $1.79 per share, up from $95.8 million, or $1.76 per share a year earlier, citing customer growth and higher rates. Retail revenues per MWh fell to $27.5 from $44.0. For FY2026, it raised the lower end of EPS guidance to $6.30-$6.45 from $6.25-$6.45.

Original reporting
Published Jul 30, 2026, 4:45 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 30, 2026, 5:19 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$IDA
Bullish
medium confidence
Mentioned
$IDA
Relevance
8/10
AlphAI data visualization · based on rttnews.com
Decision brief

The 30-second read

$IDABullishMed
01

Why it matters

The key new trading input is the FY2026 EPS guidance range update, raised at the lower end, alongside a higher Q2 net income figure. However, the article also flags a decline in retail revenues per MWh (excluding large contract customers), which may temper enthusiasm.

02

Market read

Traders can update positions based on the fresh EPS guidance range and the disclosed drivers of Q2 profitability.

03

What to watch

Guidance assumes normal weather and limited use of additional tax credits, so deviations in weather or regulatory/tax-credit utilization could narrow the upside.

Relevance 8/10Novelty 7/10Timing: reported Q2 results and FY2026 guidance raise on 2026-07-30

Background

IDACORP is the parent of Idaho Power, a regulated utility whose earnings are influenced by customer growth, rate changes, and regulatory mechanisms including tax credits.

Company-level read

Ticker impact

$IDABullishMedium confidence
Context

IDACORP reported higher Q2 profit and raised the lower end of FY2026 EPS guidance to $6.30 to $6.45.

Expected impact

Likely modest positive bias for IDA, with follow-through depending on whether investors focus on the guidance raise versus weaker retail revenue per MWh.

Evidence & confidence

The article discloses a fresh guidance change (lower end raised) plus Q2 profit beat drivers, which are actionable for positioning, though the range change is limited and one revenue metric declined.

Market effects

Reinforces the regulated-utility narrative that customer growth and rate changes can offset operational headwinds.

Supports sentiment for Idaho power/regional utility demand and rate recovery expectations.

Limited global spillover; primarily a US regulated utility read-through.

Counterpoint

The retail revenues per MWh excluding large contract customers fell sharply, suggesting underlying pricing or mix pressure despite the headline profit improvement.

Key entities

  • IDACORP, Inc.

    Reported higher Q2 profit and raised the lower end of FY2026 EPS guidance to $6.30 to $6.45.

  • Idaho Power

    Operational driver referenced for customer growth, rate changes, and tax-credit usage assumptions.

  • Lisa Grow

    CEO who attributed results to customer growth, rate changes, and large contract revenues.

Related articles

$IDAMed

IDACORP, Inc. Announces Second Quarter 2026 Results, Increases Lower-End of Earnings Guidance Range

IDACORP INC (IDA) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 July 30, 2026 IDACORP, Inc. Announces Second Quarter 2026 Results, Increases Lower-End of Earnings Guidance Range BOISE, Idaho--IDACORP, Inc. (NYSE: IDA) reported second quarter 2026 net income attributable to IDACORP of $102.6 million, or $1.79 per diluted share, co

$LWHighAI 9/10

Lamb Weston Stock Jumps As Beat-And-Raise Ignites Turnaround Hopes

Lamb Weston Holdings Inc. (NYSE: LW) stock rose 4.15% after reporting Q1 FY27 revenue of $1.67B (up 1%) and adjusted EPS of $0.75 (beating estimates). The company raised its FY27 adjusted EPS guidance to $3.05–$3.35. Analysts reacted with mixed price target increases, citing strong North American performance but noting debt and EMEA challenges.

$LWHighAI 9/10

Lamb Weston Stock Jumps After Earnings Beat And Guidance Hike

Lamb Weston Holdings Inc. (NYSE: LW) stock rose 4.15% after reporting Q3 revenue of $1.67B and adjusted EPS of $0.75, beating estimates. The company raised FY27 guidance, with adjusted EPS now expected between $3.05 and $3.35. Analysts upgraded targets, with some setting a $58 price target. The stock has gained 20% in two weeks, driven by strong North American performance and cost savings.

$REGNMed

Regeneron reports sustained efficacy for FOP treatment Pasatru

Regeneron Pharmaceuticals reported 84-week trial data for Pasatru, showing sustained efficacy in treating fibrodysplasia ossificans progressiva. Compared to placebo, Pasatru had fewer new lesions and flare-ups. Common side effects included acne and epistaxis. The FDA approved Pasatru based on 56-week data, and a regulatory review is ongoing in Europe. Regeneron plans a Phase 3 trial in younger patients later this year.

$REGNMed

Regeneron Reports Sustained 84-Week Efficacy Data for Pasatru in Adults With FOP

Regeneron (NASDAQ: REGN) reported 84-week data from the Phase 3 OPTIMA trial showing sustained efficacy of Pasatru in adults with FOP, reducing new HO lesions and flare-ups. The trial met its primary endpoint at 56 weeks, with continued benefits observed at 84 weeks. Pasatru was FDA-approved based on the 56-week trial results. The company plans to initiate a Phase 3 trial in adolescents and children with FOP later this year.